G 229 (Lamotrigine (chewable, dispersible) 25 mg)

Pill imprint G 229 has been identified as Lamotrigine (chewable, dispersible) 25 mg.

Lamotrigine is used in the treatment of bipolar disorder; seizure prevention; anxiety; schizoaffective disorder; depression (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for G 229 (Lamotrigine (chewable, dispersible) 25 mg)

Lamotrigine (chewable, dispersible) 25 mg G 229
Lamotrigine (chewable, dispersible) 25 mg G 229
Lamotrigine (chewable, dispersible)
Imprint:
G
229
Strength:
25 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Triazine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Glenmark Generics Inc.
National Drug Code (NDC):
68462-0229
Inactive Ingredients:
aspartame
silicon dioxide
magnesium stearate
microcrystalline cellulose
povidone k25

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web3)